SIDE-BY-SIDE EVIDENCE

Compare evidence.
Keep the context.

Select 2–3 profiles from the English Library. Class and grade describe evidence and regulatory context, not comparative effectiveness or suitability for an individual.

Choose profiles

SIDE-BY-SIDE EVIDENCE VIEW

Compare selected profiles

Evidence comparison · not a treatment ranking

Evidence boundaries, not cross-trial treatment outcomes
Molecule	Boldenone cypionate	Boldenone undecylenate	1-Testosterone cypionate / Dihydroboldenone
Research Topic	Clinical / Endocrine Pharmacology	Clinical / Endocrine Pharmacology	Clinical / Endocrine Pharmacology
Pharmacology	Unapproved ester of the anabolic steroid boldenone	Veterinary anabolic-androgenic steroid	Synthetic anabolic-androgenic steroid; not testosterone cypionate
PrimeCore Class	Class BInvestigational	Class BInvestigational	Class BInvestigational
Evidence Grade	Grade EPreclinical evidence	Grade DLimited / observational evidence	Grade EPreclinical evidence
Evidence boundary	Boldenone cypionate is classified here as Unapproved ester of the anabolic steroid boldenone. No adequate human therapeutic evidence or authorised product was identified. No FDA-approved human medicine was identified; prohibited by WADA at all times. A catalogue name does not establish identity, formulation, quality or authorisation, and this page provides no dosage, mixing, injection or purchasing instructions.	Boldenone undecylenate is classified here as Veterinary anabolic-androgenic steroid. Veterinary product history and doping detection do not establish human therapeutic benefit. No FDA-approved human medicine was identified; prohibited by WADA at all times. A catalogue name does not establish identity, formulation, quality or authorisation, and this page provides no dosage, mixing, injection or purchasing instructions.	1-Testosterone cypionate / Dihydroboldenone is classified here as Synthetic anabolic-androgenic steroid; not testosterone cypionate. Human therapeutic evidence is sparse and catalogue formulations are not authenticated. No FDA-approved human product was identified; anabolic agents are prohibited by WADA at all times. A catalogue name does not establish identity, formulation, quality or authorisation, and this page provides no dosage, mixing, injection or purchasing instructions.
Unknowns	Insufficient data in the current dataset	Insufficient data in the current dataset	Insufficient data in the current dataset
Limitations	Boldenone cypionate molecule or active moiety ≠ ester/salt ≠ formulation ≠ brand ≠ supplier product; biological plausibility or historical use ≠ current approval ≠ safe performance use	Boldenone undecylenate molecule or active moiety ≠ ester/salt ≠ formulation ≠ brand ≠ supplier product; biological plausibility or historical use ≠ current approval ≠ safe performance use	1-Testosterone cypionate / Dihydroboldenone molecule or active moiety ≠ ester/salt ≠ formulation ≠ brand ≠ supplier product; biological plausibility or historical use ≠ current approval ≠ safe performance use
Sources	NIH PubChem · Boldenone cypionate identity record FDA · Bodybuilding and steroid-like product safety warning WADA · 2026 Prohibited List	DEA · Steroids Drug Fact Sheet NIDA · Steroids and other APEDs WADA · 2026 Prohibited List	NIH PubChem · 1-Testosterone cypionate / Dihydroboldenone identity record FDA · Bodybuilding and steroid-like product safety warning WADA · 2026 Prohibited List
Read more	Read English overview Complete evidence profile (Thai)	Read English overview Complete evidence profile (Thai)	Read English overview Complete evidence profile (Thai)

This table does not compare doses, cross-trial outcomes or individual suitability. Missing information does not establish an absence of risk.

Choose another comparison

Continue reading

Missing fields mean information is unavailable in the current structured dataset, not that a molecule has no risks or uncertainties. English translations retain the original evidence boundaries. Where translation is not yet verified, the original Thai excerpts remain available under an explicit label. Sources retain their original language.

10 questions before drawing conclusions

Compare evidence.Keep the context.

Continue reading

Contact PrimeCoreBio

Compare evidence.
Keep the context.